The National Alliance of State & Territorial AIDS Directors (NASTAD) was awarded a $6,166,318 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the Capacity Building Assistance (CBA) for High-Impact HIV Prevention program (CFDA 93.834). This five-year award, spanning from September 2024 to March 2029, supports NASTAD's efforts to build the capacity of healthcare organizations, community-based organizations, and state/local health departments to implement...
This federal Cooperative Agreement award, with a total funding amount of $2,745,600.00, was issued by the Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Health Department Based program (CFDA 93.940). The award, titled "MODELING HIV, VIRAL HEPATITIS, STI, AND TB TO IMPROVE PUBLIC HEALTH - CAMP 3.0: THE COALITION FOR APPLIED MODELING FOR PREVENTION," aims to support comprehensive HIV prevention, surveillance, and treatment efforts across the United...
The federal Cooperative Agreement award, with ID NU38PW000004, was provided by the National Center for Chronic Disease Prevention and Health Promotion, a division of the Centers for Disease Control and Prevention (CDC). The $1,849,714.00 award, with a start date of August 1, 2024 and an end date of July 31, 2029, falls under the CDC's Assistance Programs for Chronic Disease Prevention and Control (CFDA 93.945) federal grant program. The primary purpose of this Cooperative Agreement is to...
This federal Cooperative Agreement award from the National Center for HIV/AIDS, part of the Centers for Disease Control and Prevention (CDC), provides $12,784,460 in funding to Health Research, Inc.'s Aids Institute Division from August 1, 2024 to May 31, 2029. The award supports the HIV Prevention Activities Non-Governmental Organization Based program (CFDA 93.939) to implement comprehensive HIV prevention and surveillance programs in New York that align with the national Ending the HIV...
This Project Grant award, totaling $2,150,000, was issued by the Health Resources and Services Administration (HRSA) under the HIV Emergency Relief Project Grants program (CFDA 93.914). The award will support the National Alliance of State & Territorial AIDS Directors (NASTAD) in providing training and technical assistance to HRSA-25-065 Ending the HIV Epidemic: A Plan for America - Systems Coordination Provider (EHE SCP) recipients. NASTAD aims to empower jurisdictions to improve linkage,...
The Washington State Department of Health (DOH) and Public Health Seattle-King County (PHSKC) were awarded a $14,659,997 Cooperative Agreement by the National Center for HIV/AIDS (CFDA 93.939 - HIV Prevention Activities Non-Governmental Organization Based) to implement high-impact HIV prevention and surveillance programs. The award aims to strengthen comprehensive patient-centered interventions to locate and treat persons with HIV disease, protect people at high risk of HIV infection, and move...
The Centers for Disease Control and Prevention (CDC) awarded a $1,080,667 Cooperative Agreement (CFDA 93.006 - State and Territorial and Technical Assistance Capacity Development Minority HIV/AIDS Demonstration Program) to the American Public Health Association (APHA) to build and maintain strategic partnerships between state/local health departments and cross-sectoral/community-based organizations. This 5-year award, running from Aug 1, 2024 to Jul 31, 2029, will support capacity development,...
This $7,888,424 Cooperative Agreement was awarded by the Centers for Disease Control and Prevention (CDC) under the Capacity Building Assistance (CBA) for High-Impact HIV Prevention program (CFDA 93.834). The award, effective August 30, 2024 through March 31, 2029, supports two main components: eLearning training for high-impact HIV prevention programs Organization/workforce development and management for community-based organizations The prime recipient, HealthHIV, is a national non-profit...
The federal Cooperative Agreement award, totaling $1,028,600.00, was granted by the National Center for Emerging and Zoonotic Infectious Diseases to the California Department of Public Health (CDPH) on September 30, 2024. The award is part of the Sexually Transmitted Diseases (STD) Prevention and Control Grants program (CFDA 93.977), which aims to strengthen STD prevention and control efforts across eligible jurisdictions through cooperative agreements. Under this Cooperative Agreement, CDPH...
This federal Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation's Health program (CFDA 93.421) provides $6,986,703.00 in funding to the Association of State and Territorial Health Officials (ASTHO) from August 1, 2024 to July 31, 2029. The award supports ASTHO's efforts to strengthen public health infrastructure, workforce development, data...
This Cooperative Agreement award in the amount of $1,900,000.00 was issued by the National Center for Emerging and Zoonotic Infectious Diseases, part of the U.S. Department of Health and Human Services, under the Viral Hepatitis Prevention and Control (CFDA 93.270) federal grant program. The award aims to strengthen public health systems and services through national partnerships to improve and protect the nation's health, specifically focusing on the public health workforce at state, local, and territorial health departments.
The primary awardee, the National Alliance of State & Territorial AIDS Directors (NASTAD), will use the funding to provide technical assistance, training, and capacity building services to support federal agencies and public health organizations across the U.S. in implementing high-impact prevention initiatives and addressing health disparities related to HIV/AIDS, hepatitis, and drug user health. The award includes a $795,000 sub-grant to the Council of State and Territorial Epidemiologists, Inc. (CSTE) to leverage their technical expertise in HIV surveillance, cluster detection, and outbreak response to support NASTAD's collaborative project with the Centers for Disease Control and Prevention.